What is Syndax Pharmaceuticals's net income?

Syndax Pharmaceuticals (SNDX) reported net income of -$42.67M in Q1 2026.

How has Syndax Pharmaceuticals's net income changed year-over-year?

Syndax Pharmaceuticals's net income increased by 49.7% year-over-year, from -$84.85M to -$42.67M.

What is the long-term trend for Syndax Pharmaceuticals's net income?

Over 4 years (2021 to 2025), Syndax Pharmaceuticals's net income has grown at a 84.0% compound annual growth rate (CAGR), from $24.93M to -$285.42M.

What does net income mean?

Net income as the starting point for the indirect method operating cash flow reconciliation.

Syndax Pharmaceuticals SNDX Net Income

Net Income at other companies

BiogenBIIB

$319.5M+32.8%

IncyteINCY

$303.33M+91.7%

SELLAS Life Sciences Group, Inc.SLS

-$8.41M-44.6%

AbbVieABBV

$697M-45.9%

ArriVent BioPharma, Inc.AVBP

-$43.32M+32.7%

Viridian Therapeutics, Inc.VRDN

-$104.9M-20.7%

Segments

By segment

See full

Biopharmaceutical Cancer Therapeutics-$42.67M+49.7%

Other financials

Income statement

See full

Revenue$64.9M+224%

Operating income-$34.2M+59.2%

Net income-$42.7M+49.7%

EPS (diluted)-$0.48+51.0%

Balance sheet

See full

Cash & equivalents$130.9M-15.0%

Total debt$350.5M+4.2%

Total equity$41.6M-80.6%

Total assets$472.7M-26.2%

Cash flow

See full

Operating cash flow-$50.3M+47.1%

CapEx$46.8K—

Free cash flow-$80.8M-17.6%

Valuation

See full

Market cap$1.74B+95.0%

Enterprise value$1.96B+84.0%

P/S8×-12.4×

Profitability

See full

Operating margin-102.8%-47.8pp

Net margin-111.9%-51.5pp

FCF margin-187.2%-85.4pp

Returns & leverage

See full

Return on equity-189.5%-8,509pp

Debt / equity8.4×+6.9×

Current ratio5.5×-0.3×

Where this comes from

Reported directly by Syndax Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ProfitLoss.

The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Syndax Pharmaceuticals's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Syndax Pharmaceuticals's net income?: Syndax Pharmaceuticals (SNDX) reported net income of -$42.67M in Q1 2026.
How has Syndax Pharmaceuticals's net income changed year-over-year?: Syndax Pharmaceuticals's net income increased by 49.7% year-over-year, from -$84.85M to -$42.67M.
What is the long-term trend for Syndax Pharmaceuticals's net income?: Over 4 years (2021 to 2025), Syndax Pharmaceuticals's net income has grown at a 84.0% compound annual growth rate (CAGR), from $24.93M to -$285.42M.
What does net income mean?: Net income as the starting point for the indirect method operating cash flow reconciliation.